The post Morning Minute: a16z Raises $15B, Targets AI & Crypto appeared on BitcoinEthereumNews.com. Morning Minute is a daily newsletter written by Tyler WarnerThe post Morning Minute: a16z Raises $15B, Targets AI & Crypto appeared on BitcoinEthereumNews.com. Morning Minute is a daily newsletter written by Tyler Warner

Morning Minute: a16z Raises $15B, Targets AI & Crypto

Morning Minute is a daily newsletter written by Tyler Warner. The analysis and opinions expressed are his own and do not necessarily reflect those of Decrypt. Subscribe to the Morning Minute on Substack.

GM!

Today’s top news:

  • Crypto majors flat over the weekend; BTC at $90,600
  • XMR jumps to $600 overnight and new ATH, up 33% on week
  • Jerome Powell releases message claiming charges are due to his not complying with Trump, gold+silver spike
  • a16z raises $15M across funds to invest in America’s future, AI & crypto at forefront
  • X announces plans for Smart Cashtags, showing live charts along with tickers

💰 a16z Reloads With $15B, Targets AI & Crypto

a16z is back with its biggest fundraise ever.

And crypto is at the forefront.

📌 What Happened

Andreessen Horowitz (a16z) announced it raised over $15B across multiple new funds, one of the largest VC fundraises in years.

Per a16z’s own breakdown, the raise includes: Growth ($6.75B), Apps ($1.7B), Infrastructure ($1.7B), American Dynamism ($1.176B), Bio + Health ($700M), plus $3B in other strategies.

For historical context, a16z has been a top crypto allocator for years, raising dedicated vehicles including:

  • $300M for its first crypto fund (2018)
  • $515M Crypto Fund II (2020)
  • $2.2B Crypto Fund III (2021)
  • $4.5B Crypto Fund IV (2022), including $1.5B seed + $3B venture

Some of their notable investments across that time include Coinbase, Solana, Uniswap, OpenSea, and Phantom, plus more recent deals like Kalshi and EigenLayer.

🗣️ What They’re Saying

“As the American leader in venture capital, the fate of new technology in the United States rests partly on our shoulders. Our mission is ensuring that America wins the next 100 years of technology.” – Ben Horowitz, a16z cofounder

🧠 Why It Matters

It’s interesting to take a peek under the hood here to see what a16z is investing in, to get a glimpse of their view of the future:

  • AI infrastructure: a16z is leaning into compute, tooling, and platform layers that will power the next decade of software
  • “American Dynamism”: defense, housing, supply chains, and other “national interest” categories
  • Infrastructure + Apps: the picks-and-shovels layer that can survive multiple market cycles (and typically captures value even when narratives rotate).

For crypto specifically, it’s:

  • more stablecoin and payments rails
  • more tokenized assets and settlement
  • more infrastructure that can onboard institutions
  • more crypto x AI convergence

It may be a bit “boring,” but that’s likely an apt way to discuss this next phase of crypto. We’re set up for a boring maturity phase.

Stablecoin adoption, tokenized asset adoption and more institutional infrastructure.

The biggest wildcard is how crypto and AI will converge and what investment opportunities will arise from it. We will be watching closely…

🌎 Macro Crypto and Markets

A few headlines that stood out:

  • Crypto majors are mostly flat headed into Monday open; BTC even at $90,600; ETH +1% at $3,110, SOL +2% at $140; XRP -2% to $2.04
  • IP (+20%) and XMR (+15%) led top movers; XMR hit a new ATH at $590
  • Fed Chair Jerome Powell released a video message claiming that the criminal charges he faces are due to his not cutting interest rates in line with Trump’s wishes
  • X (Twitter) announced plans for “Smart Cashtags” to show crypto and stock prices live next to tickers
  • VanEck projected Bitcoin could reach $53M by 2050, outlining long-term adoption, trade settlement and store-of-value assumptions driving 29% annual growth
  • Andreessen Horowitz (a16z) raised $15B to fund American Dynanism, with AI and crypto at the forefront
  • Ripple received FCA approval to scale crypto payments in the UK
  • BNY Mellon debuted tokenized deposits for institutional and digital-native clients
  • A new House bill would bar lawmakers and federal officials from using prediction markets
  • Tether froze $182M in USDT linked to Venezuela oil trades

In Corporate Treasuries / ETFs

  • The BTC ETFs saw another $250M in net outflows on Friday, now with 4 straight days of outflows

In Memes / Onchain Movers

  • Meme majors were mostly red; Doge -3%, Shiba -3%, PEPE -2%, Bonk -2%, Pengu -2%, WIF -3% and Fartcoin -4%
  • Testicle was a top mover onchain, jumping 20% to $20M; Ralph Wiggum (+125%), SPSC (+45%) and SOL (+23%) led other notable onchain movers

💰 Token, Airdrop & Protocol Tracker

  • Pump Fun teased changes to their creator fee sharing, changing coin creation incentives
  • Infinex closed their ICO with 44% oversubscription
  • Trove completed its ICO with $11.5M raised, and an extension that went live then was walked back; TGE will occur on Jan 20th
  • Rekt Drinks’ World Star Cherry Cola sale goes live today at 1 pm ET
  • Rain announced a $250M raise at $1.95B valuation to expand its stablecoin service

🚚 What is happening in NFTs?

  • NFT leaders were slightly green over the weekend; Punks even at 28.8 ETH, Pudgy -1% at 4.83 ETH, and BAYC +1% at 5.38 ETH; Hypurr -3% to 514 HYPE
  • Good Vibes Club (+26%), Genuine Undead (+28%) and Chimpers (+28%) led top movers
  • A Spirit Azuki sold for 28 ETH ($87,500)

Daily Debrief Newsletter

Start every day with the top news stories right now, plus original features, a podcast, videos and more.

Source: https://decrypt.co/354228/morning-minute-a16z-raises-15b-targets-ai-crypto

Market Opportunity
null Logo
null Price(null)
--
----
USD
null (null) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

BullZilla, World Liberty Financial, MoonBull, La Culex, and Polkadot (DOT) are taking the spotlight among emerging and established crypto projects […] The post 5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale appeared first on Coindoo.
Share
Coindoo2025/10/18 08:15
Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26